CoChat

Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Objectives Artificial intelligence (AI), including predictive analytics, has great potential to improve the care of common chronic conditions with high morbidity and mortality. However, there are still many challenges to achieving this vision. The goal of this project was to develop and apply methods for enhancing chronic disease care using AI. Methods Using a dataset of 27,904 patients with diabetes, an analytical method was developed and validated for generating a treatment pathway graph which consists of models that predict the likelihood of alternate treatment strategies achieving care goals. An AI-driven clinical decision support system (CDSS) integrated with the electronic health record (EHR) was developed by encapsulating the prediction models in an OpenCDS Web service module and delivering the model outputs through a SMART on FHIR (Substitutable Medical Applications and Reusable Technologies on Fast Healthcare Interoperability Resources) web-based dashboard. This CDSS enables clinicians and patients to review relevant patient parameters, select treatment goals, and review alternate treatment strategies based on prediction results. Results The proposed analytical method outperformed previous machine-learning algorithms on prediction accuracy. The CDSS was successfully integrated with the Epic EHR at the University of Utah. Conclusion A predictive analytics-based CDSS was developed and successfully integrated with the EHR through standards-based interoperability frameworks. The approach used could potentially be applied to many other chronic conditions to bring AI-driven CDSS to the point of care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0041-1728757

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Treatment pathway graph.
Fig. 1 Treatment pathway graph.CC BY-NC-ND · PubMed Central
Fig. 2 Valid HbA1c range calculation process. HbA1C, hemoglobin A1c.
Fig. 2 Valid HbA1c range calculation process. HbA1C, hemoglobin A1c.CC BY-NC-ND · PubMed Central
Fig. 3 Model construction on treatment pathway graph.
Fig. 3 Model construction on treatment pathway graph.CC BY-NC-ND · PubMed Central
Fig. 4 Stacked model.
Fig. 4 Stacked model.CC BY-NC-ND · PubMed Central
Fig. 5 Model training, testing, and validation process.
Fig. 5 Model training, testing, and validation process.CC BY-NC-ND · PubMed Central
Fig. 6 Overview of clinical decision support system.
Fig. 6 Overview of clinical decision support system.CC BY-NC-ND · PubMed Central
Fig. 7 Predicted curves for simulated patients: Three methods were applied to simulated patients on the transition from MET to MET + SUL. Target achievement probabilities are predicted for controlling HbA1c less than 7.0% in 3 months. Actual ratios were calculated by grouping records on the transition by 1.0%. The error bars show 95% confidence intervals of the actual ratio. MET, metformin; SUL, sulfonylureas.
Fig. 7 Predicted curves for simulated patients: Three methods were applied to simulated patients on the transition from MET to MET + SUL. Target achievement probabilities are predicted for controlling HbA1c less than 7.0% in 3 months. Actual ratios were calculated by grouping records on the transition by 1.0%. The error bars show 95% confidence intervals of the actual ratio. MET, metformin; SUL, sulfonylureas.CC BY-NC-ND · PubMed Central
Fig. 8 Options comparison tab in the dashboard: The clinician and patient can review potential treatment options in detail using this view. Comparative data are provided for three treatment options. The “success rate” shows the predicted probability of treatment success for each potential treatment regimen. The effect of 5% body weight loss is also shown for the current medication regimen. The predictions are specific to the current patient and are based on the various data points that have been pulled in from the EHR. Clinicians and patients can also review the benefits and risks of each medication option. In addition, cost information is provided, including the National Average Drug Acquisition Cost. The patient's insurance information is pulled in from the EHR, and coverage information specific to the patient's insurance is provided (All synthetic data). EHR, electronic health record.
Fig. 8 Options comparison tab in the dashboard: The clinician and patient can review potential treatment options in detail using this view. Comparative data are provided for three treatment options. The “success rate” shows the predicted probability of treatment success for each potential treatment regimen. The effect of 5% body weight loss is also shown for the current medication regimen. The predictions are specific to the current patient and are based on the various data points that have been pulled in from the EHR. Clinicians and patients can also review the benefits and risks of each medication option. In addition, cost information is provided, including the National Average Drug Acquisition Cost. The patient's insurance information is pulled in from the EHR, and coverage information specific to the patient's insurance is provided (All synthetic data). EHR, electronic health record.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 92

Metadata

Authors
Tarumi, S., Takeuchi, W., Chalkidis, G., Rodriguez-Loya, S., Kuwata, J., Flynn, M., Turner, K. M., Sakaguchi, F. H., Weir, C., Kramer, H., Shields, D. E., Warner, P. B., Kukhareva, P., Ban, H., & Kawamoto, K.
Affiliations
  • Department of Media Intelligent Processing Research, Center for Technology Innovation Artificial Intelligence, Hitachi Ltd., Kokubunji, Tokyo, Japan
  • Hitachi (Japan) (JP)
  • University of Utah (US)
Venue
Methods of Information in Medicine
Published
2021-05-11
Volume
60
Issue
S 01
Pages
e32-e43
ISSN
  • 0026-1270 (ISSN-L)
  • 2511-705X
OpenAlex
W3163731260
Cited by
84
References
44
Citations by year
2026: 15 · 2025: 30 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 3
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • Methods of Information in Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Hitachi, Ltd.
Topics
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
  • Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
Keywords
artificial intelligence, clinical decision support systems, type 2 diabetes, chronic care, predictive analytics, electronic health record integration, SMART on FHIR, Epic EHR, interoperability
MeSH terms
Artificial Intelligence, Chronic Disease, Diabetes Mellitus, Type 2, Humans, Decision Support Systems, Clinical, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1055/s-0041-1728757
The paper
Tarumi, S., Takeuchi, W., Chalkidis, G., Rodriguez-Loya, S., Kuwata, J., Flynn, M., Turner, K. M., Sakaguchi, F. H., Weir, C., Kramer, H., Shields, D. E., Warner, P. B., Kukhareva, P., Ban, H., & Kawamoto, K. (2021). Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus. Methods of Information in Medicine. https://doi.org/10.1055/s-0041-1728757

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.